The FDA Law Blog

NOVEMBER 10, 2024

By Sarah Wicks & James E. Valentine — The U.S. Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.

FDA 69

FDA Labelling 69

Fierce Healthcare

NOVEMBER 10, 2024

Rula Health has teamed up with Amazon Health Services to expand access to mental healthcare. | Amazon customers can search for mental health support using keywords like “stress relief” or “anxiety relief” to find providers who take their insurance and meet their needs. Rula is available via search, product detail pages or navigating the discovery bar.

Insurance 128

Insurance 128

pharmaphorum

NOVEMBER 10, 2024

Johnson & Johnson looks on course to make Darzalex the first approved drug therapy for smouldering multiple myeloma, after a phase 3 win

Labelling 108

Labelling 108

Pharmacy Times

NOVEMBER 10, 2024

Vitamin K2 displayed a marked reduction in cramp frequency compared to a placebo.

101

101

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

NOVEMBER 10, 2024

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal. | Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal. RCA is a management services organization that operates a network of retina specialists and the deal will bolster Cencora's specialty drug business.

98

98

Pharmaceutical Technology

NOVEMBER 10, 2024

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in the field.

52

52

pharmaphorum

NOVEMBER 10, 2024

Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, Yazen Health, and Nema Health, wearables developer Alimetry, and clinical trial automation startup Research Grid.Digital pathology specialist Aignostics, which develops artificial intelligence algorithms to glean information from medical images and combine it with epidemiological, clinical, and genomic data, has completed a $34 million Series B financing.

110

110

Med Ed 101

NOVEMBER 10, 2024

Are you gearing up for the BCPS exam in 2025 and looking for the best resources to help you succeed? We’ve got some exciting news that will make your preparation easier and more affordable! For a limited time, we’re offering $100 OFF our comprehensive BCPS Exam Study Materials (1 Year All Access Pass), designed by […] The post 2025 BCPS Study Materials $100 Discount AND FREE Audible Book!

105

105